Standard

Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model. / Shchelkunov, S. N.; Razumov, I. A.; Kolosova, I. V. et al.

In: Doklady Biochemistry and Biophysics, Vol. 478, No. 1, 01.01.2018, p. 30-33.

Research output: Contribution to journal › Article › peer-review

Harvard

Shchelkunov, SN, Razumov, IA, Kolosova, IV, Romashchenko, AV & Zavjalov, EL 2018, 'Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model', Doklady Biochemistry and Biophysics, vol. 478, no. 1, pp. 30-33. https://doi.org/10.1134/S1607672918010088

APA

Shchelkunov, S. N., Razumov, I. A., Kolosova, I. V., Romashchenko, A. V., & Zavjalov, E. L. (2018). Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model. Doklady Biochemistry and Biophysics, 478(1), 30-33. https://doi.org/10.1134/S1607672918010088

Vancouver

Shchelkunov SN, Razumov IA, Kolosova IV, Romashchenko AV, Zavjalov EL. Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model. Doklady Biochemistry and Biophysics. 2018 Jan 1;478(1):30-33. doi: 10.1134/S1607672918010088

Author

Shchelkunov, S. N. ; Razumov, I. A. ; Kolosova, I. V. et al. / Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model. In: Doklady Biochemistry and Biophysics. 2018 ; Vol. 478, No. 1. pp. 30-33.

BibTeX

@article{001854b27af249cfa7e7183f1fe6bedb,
title = "Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model",
abstract = "The possibility of glioblastoma virotherapy at intravenous injection of the LIVP–GFP recombinant virus was studied in experimental model of orthotopic xenotransplantation of human glioblastoma cell line U87 to SCID laboratory mice. The LIVP–GFP recombinant virus deficient for thymidine kinase exhibited a significantly greater oncolytic capacity than the original LIVP virus, and an intravenous injection of LIVP–GFP at the early stages of tumorigenesis in mouse brain in most cases resulted in the lysis of the tumor.",
author = "Shchelkunov, {S. N.} and Razumov, {I. A.} and Kolosova, {I. V.} and Romashchenko, {A. V.} and Zavjalov, {E. L.}",
note = "Publisher Copyright: {\textcopyright} 2018, Pleiades Publishing, Ltd.",
year = "2018",
month = jan,
day = "1",
doi = "10.1134/S1607672918010088",
language = "English",
volume = "478",
pages = "30--33",
journal = "Doklady Biochemistry and Biophysics",
issn = "1607-6729",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "1",

}

RIS

TY - JOUR

T1 - Virotherapy of the Malignant U87 Human Glioblastoma in the Orthotopic Xenotransplantation Mouse SCID Model

AU - Shchelkunov, S. N.

AU - Razumov, I. A.

AU - Kolosova, I. V.

AU - Romashchenko, A. V.

AU - Zavjalov, E. L.

N1 - Publisher Copyright: © 2018, Pleiades Publishing, Ltd.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The possibility of glioblastoma virotherapy at intravenous injection of the LIVP–GFP recombinant virus was studied in experimental model of orthotopic xenotransplantation of human glioblastoma cell line U87 to SCID laboratory mice. The LIVP–GFP recombinant virus deficient for thymidine kinase exhibited a significantly greater oncolytic capacity than the original LIVP virus, and an intravenous injection of LIVP–GFP at the early stages of tumorigenesis in mouse brain in most cases resulted in the lysis of the tumor.

AB - The possibility of glioblastoma virotherapy at intravenous injection of the LIVP–GFP recombinant virus was studied in experimental model of orthotopic xenotransplantation of human glioblastoma cell line U87 to SCID laboratory mice. The LIVP–GFP recombinant virus deficient for thymidine kinase exhibited a significantly greater oncolytic capacity than the original LIVP virus, and an intravenous injection of LIVP–GFP at the early stages of tumorigenesis in mouse brain in most cases resulted in the lysis of the tumor.

UR - http://www.scopus.com/inward/record.url?scp=85043993175&partnerID=8YFLogxK

U2 - 10.1134/S1607672918010088

DO - 10.1134/S1607672918010088

M3 - Article

C2 - 29536305

AN - SCOPUS:85043993175

VL - 478

SP - 30

EP - 33

JO - Doklady Biochemistry and Biophysics

JF - Doklady Biochemistry and Biophysics

SN - 1607-6729

IS - 1

ER -

ID: 12027962